Department of Microbiology, Faculty of Veterinary Medicine, Ataturk University, 25240, Erzurum, Turkey.
Ataturk University Vaccine Application, and Development Center, Ataturk University, 25240, Erzurum, Turkey.
Mol Biol Rep. 2023 Jul;50(7):5949-5956. doi: 10.1007/s11033-023-08532-z. Epub 2023 May 31.
Escherichia coli ST131 is a pandemic clone associated with multidrug resistance, starting with beta-lactamase production and fluoroquinolone resistance in the first place, leading to significant systemic infections. Clones that develop due to the frequency of antimicrobial resistance and the rate of spread in our country are important issues that need to be investigated. This study aims to investigate the incidence of ST131which is a "high-risk pandemic clone E. coli" in ESBL-producing and non-ESBL-producing strains, as well as their biofilm-forming abilities and antibiotic resistance rates.
A total of 86 E. coli isolates were used in the study. Bacterial identifications were performed by conventional and automated methods. The double disc synergy method was used to demonstrate the presence of ESBL. Molecular studies in all E. coli strains were performed by real-time PCR method.
86 strains were studied, of which 83.72% were urine, 6.98% were wound, 4.65% were blood, and 2.33% were tracheal aspirate and sputum. 79.07% of these strains were ESBL-positive. 58.1% of the strains were female, whereas 41.9% were male patients, and the average age was 46.2. Out of 86 strains, 38.72% were ST131 positive, the H30 subclone was detected in 27.27% of them, and the H30-Rx subclone was detected in all of the H30 subclone positive strains. The presence of the ESBL resistance gene was detected at the rate of TEM 41.86%, SHV 37.21%, CTX-M 36.04%, and OXA 4.65%. Most commonly SHV gene (54.54%) was seen in ST131 clone-positive samples. Finally, while it was found that 48.83% of the strains formed biofilm by any method, biofilm formation was detected in 69.7% of the samples that were positive for the ST131 clone.
Our study can reveal the dramatic prevalence of the ESBL-producing E. coli strains along with the high-risk ST131 clone, the dominance of the H30Rx subclone of this risky clone, as well as the importance of the influence of resistance mechanisms along with resistance and biofilm.
大肠杆菌 ST131 是一种与多药耐药性相关的流行克隆,首先是产生β-内酰胺酶和对氟喹诺酮类药物的耐药性,导致严重的全身感染。由于抗菌药物耐药性的频率和在我国的传播速度,产生的克隆是需要调查的重要问题。本研究旨在调查产生 ESBL 的大肠杆菌菌株和非产 ESBL 菌株中“高危流行克隆大肠杆菌” ST131 的发生率,以及它们的生物膜形成能力和抗生素耐药率。
本研究共使用了 86 株大肠杆菌。细菌鉴定采用常规和自动化方法。采用双碟协同法证实 ESBL 的存在。对所有大肠杆菌菌株进行实时 PCR 方法的分子研究。
共研究了 86 株菌,其中 83.72%为尿液,6.98%为伤口,4.65%为血液,2.33%为气管抽吸物和痰液。这些菌株中有 79.07%为 ESBL 阳性。其中 58.1%为女性患者,41.9%为男性患者,平均年龄为 46.2 岁。在 86 株菌中,有 38.72%为 ST131 阳性,其中 27.27%为 H30 亚克隆,所有 H30 亚克隆阳性菌株均为 H30-Rx 亚克隆。检测到 ESBL 耐药基因的存在率为 TEM 41.86%、SHV 37.21%、CTX-M 36.04%和 OXA 4.65%。最常见的 SHV 基因(54.54%)见于 ST131 克隆阳性样本。最后,虽然发现 48.83%的菌株通过任何方法都能形成生物膜,但在 ST131 克隆阳性的样本中,有 69.7%的样本检测到生物膜形成。
本研究揭示了产 ESBL 大肠杆菌菌株以及高危 ST131 克隆的惊人流行率,该高危克隆的 H30Rx 亚克隆占主导地位,以及耐药机制和耐药性与生物膜形成的重要影响。